|
|
Monday 8th November
|
|
|
|
|
|
Breast Educational Workshop: Strategies for targeted axillary dissection–Tips and tricks
|
|
|
09:15–11:15 (AUDITORIUM VII)
|
|
|
Chair: Riccardo Audisio, IT
Co-Chair: Maria Joao Cardoso, PT
|
|
09:15
|
Carbon dye
|
|
|
Speaker: Pedro Gouveia, PT
|
|
09:35
|
Magnetic markers
|
|
|
Speaker: Andreas Karakatsanis, SE
|
|
09:55
|
Intraoperative guided axillary surgery
|
|
|
Speaker: Isabel Teresa Rubio, SP
|
|
10:15
|
Need for standardization of axillary management after neoadjuvant treatment
|
|
|
Speaker: Sabrina Maaskant-Braat, NL
|
|
10:35
|
Discussion
|
|
|
|
|
|
Upper GI Scientific Symposium
|
|
|
09:15–10:45 (AUDITORIUM VI)
|
|
|
Chair: Domenico D’Ugo, IT
Co-chair: Andreas Brandl, PT
|
|
09:15
|
Prehabilitation and ERAS in Oesophageal and Gastric Cancer Surgery
|
|
|
Speaker: Jacopo Weidelmeyer, IT
|
|
09:30
|
Hereditary Diffuse Gastric Cancer–20 years on
|
|
|
Speaker: Fatima Carneiro, PT
|
|
09:45
|
Gastro data
|
|
|
Speaker: Gian Luca Baiocchi, IT
|
|
10:00
|
Frailty
|
|
|
Speaker: William Allum, UK
|
|
10:15
|
Gastric and oesophageal cancer in Portugal
|
|
|
Speaker: PaUlo Costa, PT
|
|
|
|
|
|
Peritoneal Metastasis from Gastric Cancer
|
|
|
10:45–11:15 (AUDITORIUM VI)
|
|
10:45
|
Intraperitoneal chemotherapy for patients with gastric cancer
|
|
|
Speaker: Andreas Brandl, PT
|
|
11:00
|
Cytoreductive Surgery in patients with peritoneal metastasis
|
|
|
Speaker: Beate Rau, DE
|
|
|
|
|
|
Posters in the spotlight - PSM & Interdisciplinary
|
|
|
Monday, 11:15 – 11:45 (10’ break; presentations start at 11:25)
|
|
|
Moderator: Delia Cortes-Guiral
|
|
|
ESSO40-0482 – Comparison between Arm Port and Chest Port for Central Venous Access in Breast Cancer Treatment
|
|
|
Ana Margarida Correia, PT
|
|
|
ESSO40-0348 – Timed Up and Go test and long term survival in older adults after oncologic surgery
|
|
|
Sharon Hendriks, NL
|
|
|
ESSO40-0238 – Early Postoperative Intraperitoneal Chemotherapy (EPIC) following Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Pseudomyxoma Peritonei of appendiceal origin
|
|
|
Xavier Fung, GB
|
|
|
ESSO40-0128 – A proposal for modification of PSOGI classification according to Ki-67 proliferation index in pseudomyxoma peritonei
|
|
|
Alvaro Arjona, ES
|
|
|
ESSO40-0246 – CD39 expressing M2 macrophages are elevated in the peritoneal fluid of patients with metastasis of gastric cancer
|
|
|
Vincent Wolf, DE
|
|
|
ESSO40-0426 – Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for diffuse malignant peritoneal mesothelioma is associated with promising oncological outcomes
|
|
|
Olivia A Sgarbura, FR
|
|
|
|
|
|
Plenary Session: Opening Session and Lifetime Achievement Award
|
|
|
11:45–12:30 (AUDITORIUM VII)
|
|
|
Chair: Domenico D’Ugo, IT
Co-Chair: Joaquim Abreu, PT
|
|
11:45
|
ESSO President and Scientific Chair welcome and opening remarks
|
|
|
Speaker: Domenico D’Ugo, IT
|
|
11:52
|
Local Chair welcome and opening remarks
|
|
|
Speaker: Joaquim Abreu, PT
|
|
12:00
|
Presentation of the Lifetime Achievement Award
|
|
|
Speaker: Domenico D’Ugo, IT
|
|
12:05
|
Enhancing the Future of Surgical Oncology
|
|
|
Speaker: Riccardo Audisio, SE
|
|
|
|
|
|
Interdisciplinary Symposium: Women in Surgery Session and ESSO Medal
|
|
|
12:30–13:30 (AUDITORIUM VII)
|
|
|
Chair: Lynda Wyld, UK
Co-Chair: Olivia Sgarbura, FR
|
|
12:30
|
Increasing leadership and mentoring
|
|
|
Speaker: Isabel T. Rubio, SP
|
|
12:50
|
Gender equity in surgery: How to improve it
|
|
|
Speaker: Olivia Sgarbura, FR
|
|
13:10
|
Presentation of the ESSO Medal
|
|
|
Speaker: Domenico D’Ugo, IT
|
|
13:13
|
ESSO Medal Award Lecture: Evolution in axillary surgery in breast cancer
|
|
|
Speaker: Marjut Leidenius, FI
|
|
|
|
|
|
Breast Debate: Oncoplastic surgery should be used for all patients
|
|
|
14:45–16:15 (AUDITORIUM VII)
|
|
|
Moderator: Marjut Leidenius, FI
|
|
14:45
|
Speaker in favour: Florian Fitzal, AT
|
|
15:00
|
Speaker against: Lynda Wyld, UK
|
|
15:15
|
Discussion & Voting
|
|
15:35
|
ESSO40-0304 – Ratul Quddus, GB
Outcomes from complex oncoplastic breast surgery in UK women over the age of 70. Analysis of data from the Age Gap cohort study
|
|
15:45
|
ESSO40-0428 – Isabel T. Rubio, ES
AXSANA: A European prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with NACT
|
|
15:55
|
ESSO40-0551 – Michael Golatta, DE
Imaging of Lumpectomy Surface with Large Field-of-View Confocal Laser Scanning Microscopy ‘Histolog® Scanner’ for Breast Margin Assessment in comparison with Conventional Specimen Radiography
|
|
16:05
|
ESSO40-0229 – Claudia Regis, FR
Functional cerebral MRI evaluation of the integration of breast reconstruction into the body schema
|
|
|
|
|
|
PSM Scientific Symposium: Peritoneal metastasis from colorectal cancer
|
|
|
14:45–16:15 (AUDITORIUM VI)
|
|
|
Chair: Beate Rau, DE
Co-chair: Pompiliu Piso, DE
|
|
14:45
|
CRS and HIPEC in the post PRODIGE-7 era
|
|
|
Speaker: François Quenet, FR
|
|
15:05
|
Proactive approach after PROPHYLOCHIP and COLOPEC
|
|
|
Speaker: Pompiliu Piso, DE
|
|
15:25
|
Ongoing projects in Peritoneal Surface Oncology
|
|
|
Speaker: Santiago Gonzalez-Moreno, SP
|
|
15:35
|
European School of Peritoneal Surface Oncology (ESPSO)
|
|
|
Speaker: Santiago Gonzalez-Moreno, SP
|
|
15:45
|
ESSO40-0441 – Mohammad Alyami, SA
Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for unresectable PM from Gastric Cancer, Outstanding Result From multicenter international cohort study
|
|
15:55
|
ESSO40-0648 – Clarisse Eveno, FR (ESSO40-0245 + ESSO40-0042 merged abstracts)
Ten years of French practice combined with a root cause analysis of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
|
|
16:05
|
ESSO40-0356 – Robin Lurvink, NL
The impact of open or laparoscopic surgery for colorectal cancer on the development of metachronous peritoneal metastases – results from a population-based cohort study
|
|
|
|
|
|
Posters in the spotlight (Breast Cancer)
|
|
|
Monday, 16:15 – 16:45 (10’ break; presentations start at 16:25)
|
|
|
Moderator: Niall OHiggins
|
|
|
ESSO40-0571 – Radiofrequency Tag Localisation for Breast Lesions, A single center experience
|
|
|
Huda Alnumani, GB
|
|
|
ESSO40-0597 – Persistent pain after breast cancer treatment, the underdog that is affecting breast cancer survivors
|
|
|
Bo Strijbos, NL
|
|
|
ESSO40-0257 – The evolution and refinement of magnetic-guided sentinel lymph node detection in breast cancer. A systematic review and meta-analysis
|
|
|
Eirini Pantiora, SE
|
|
|
ESSO40-0267 – Preliminary results of the MUltimodal TArgeted axillary Surgery (MUTAS) study (ClinicalTrials.gov: NCT04039893): tailoring axillary dissection in breast cancer patients with infiltrated lymph nodes
|
|
|
Maria Vernet-Tomas, ES
|
|
|
ESSO40-0471 – Triple evaluation of positive axillary nodes in breast cancer after neoadjuvant chemotherapy
|
|
|
Rita Canotilho Torres, PT
|
|
|
|
|
|
Breast Scientific Symposium: Ongoing controversies
|
|
|
16:45–18:15 (AUDITORIUM VII)
|
|
|
Chair: Isabel T. Rubio, SP
Co-chair: Lynda Wyld, UK
|
|
16:45
|
Local therapy of the primary tumor in stage IV. Anything new?
|
|
|
Speaker: Florian Fitzal, AT
|
|
17:00
|
Contralateral prophylactic mastectomy. Following USA direction in Europe
|
|
|
Speaker: Andreas Karakatsanis, SE
|
|
17:15
|
Genomic assays to help determine neoadjuvant treatment. Is it ready for prime time?
|
|
|
Speaker: Noemia Afonso, PT
|
|
17:30
|
No breast surgery for clinical and radiological complete response after neoadjuvant chemotherapy
|
|
|
Speaker: MK Tasoulis, UK
|
|
17:45
|
ESSO40-0418 – Sherko Kümmel, DE
Pembrolizumab vs placebo + chemotherapy as neoadjuvant treatment, followed by pembrolizumab vs placebo as adjuvant treatment for early triple-negative breast cancer (TNBC): Phase 3 KEYNOTE-522 study
|
|
17:55
|
ESSO40-0237 – Tina Hieken, US
Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival in HER2+ Patients with a Pathologic Complete Response to Neoadjuvant Therapy
|
|
18:05
|
ESSO40-0216 – Geoff Fisher, GB
Uncovering clinical gaps in the treatment of early HER2+ve breast cancer: An assessment of clinical practices
|
|
|
|
|
|
JOINT EDUCATIONAL ESSO WITH ESOI (European Society of Oncology Imaging)
Upper GI Educational Workshop: Gastrointestinal Stromal Tumours – presentation, management and case discussion
|
|
|
16:45–18:15 (AUDITORIUM VI)
|
|
|
Chair: Winan van Houdt, NL
Co-chair: William Allum, UK
|
|
16:45
|
Imaging of gastrointestinal stromal tumours
|
|
|
Speaker: Daniele Regge, IT
|
|
17:05
|
Systemic treatment
|
|
|
Speaker: Giovanni Grignani, IT
|
|
17:25
|
Surgical management
|
|
|
Speaker: William Allum, UK
|
|
17:45
|
TBD
|
|
|
Gerard Van Oortmerssen, NL
|
|
17:45
|
Case-based discussion
|
|
|
Discussants: Daniele Regge, IT; Winan van Houdt, NL; William Allum, UK; Giovanni Grignani, IT;Gerard Van Oortmerssen, NL
|
|
|
|
|
|
PSM Case discussion session
|
|
|
16:45–18:00 (MEETING ROOM)
|
|
|
Chair: Santiago Gonzalez-Moreno, SP
Co-chair: Andreas Brandl, PT
|
|
16:45
|
Pseudomyxoma peritonei
|
|
|
Speaker: Delia Cortes-Guiral, DE
|
|
17:10
|
Colorectal Cancer
|
|
|
Speaker: Olivia Sgarbura, FR
|
|
17:35
|
Gastric Cancer
|
|
|
Speaker: Beate Rau, DE
|
|
|
|
|
|
|
|
|
|
|
|
Tuesday 9th November
|
|
|
|
|
|
Colorectal Educational Workshop: Techniques and selected topics
|
|
|
08:30–10:30 (AUDITORIUM VII)
|
|
|
Moderator 1: Ibrahim Edhemovic, SLO
Moderator 2: Nuno Figueiredo, PT
|
|
08:30
|
TAMIS, TME, TTSS, what have we learned? (video)
|
|
|
Speaker: Antonino spinelli, it
|
|
08:50
|
Robotic TME (video)
|
|
|
Speaker: Amjad Parvaiz, gb
|
|
09:10
|
Splenic flexure mobilisation (video)
|
|
|
Speaker: Felix Aigner, DE
|
|
09:30
|
Hereditary colorectal cancer
|
|
|
Speaker: gabriela moeslein, de
|
|
09:50
|
Colorectal cancer in older patients
|
|
|
Speaker: Isacco Montroni, IT
|
|
10:10
|
Immunotherapy in colorectal cancer
|
|
|
Speaker: Geerard Beets, NL
|
|
|
|
|
|
EYSAC Educational Workshop
Dragons’ Den: Opportunity to Pitch your Trial Proposals to a Panel of Experts
|
|
|
08:30–10:30 (AUDITORIUM VI)
|
|
|
Moderators (experts’ panel): Kjetil Soreide, NO; Laura Lorenzon (IT); Wim Ceelen, BE; Gerard Van Oortmerssen, NL
|
|
08:30
|
Groundbreaking changes in surgical oncology
|
|
|
Speaker: William Allum (UK)
|
|
08:45
|
Oncology Trials vs Surgical Trials
|
|
|
Speaker: Thilo Hackert, DE
|
|
09:00
|
Understanding a multi-disciplinary team perspective about omission of surgery for early stage breast cancer
|
|
|
Speaker: Carmela Caballero, BE
|
|
09:15
|
Short-term outcomes of COLon cancer surgery with full bowel preparation (mechanical bowel preparation and oRal AntiBIotics) and no bowel preparation (COLRABI Multicenter Randomized Controlled Trial)
|
|
|
Speaker: Aleksandra Olkina, RU
|
|
09:30
|
Is TP53 Arg72Pro a risk factor for pancreatic cancer in diabetic patients?
|
|
|
Speaker: Laura Antolino, IT
|
|
|
TP53 is not a prognostic marker – clinical consequences of a generally disregarded fact
|
|
|
Speaker: Tamara Braunschmid, AT
|
|
09:45
|
Proofed Trials Discussion with panel and EYSAC experts
|
|
10:20
|
EYSAC Trial Award
|
|
|
|
|
|
Interdisciplinary Session: Immunotherapy
|
|
|
10:30–11:30 (AUDITORIUM VII)
|
|
|
Moderator: Domenico D’Ugo, IT
|
|
10:30
|
Immunotherapy in solid tumours
|
|
|
Speaker: A. Eggermont, NL
|
|
10:55
|
Immunotherapy in GI cancer
|
|
|
Speaker: Andres Cervantes, SP
|
|
11:20
|
Discussion
|
|
|
|
|
|
Posters in Spotlight - Melanoma, Sarcoma, Head & Neck and Thyroid Cancer
|
|
|
Tuesday, 11:30 – 12:00 (10’ break; presentation start at 11:40)
|
|
|
Moderator: TBD
|
|
|
ESSO40-0381 – The role of perioperative chemotherapy in primary high-grade extremity soft tissue sarcoma: A risk-stratified analysis using PERSARC
|
|
|
Ibtissam Acem, NL
|
|
|
ESSO40-0314 – A nationwide prospective clinical trial on active surveillance in patients with non-intra-abdominal desmoid-type fibromatosis; the Grafiti trial
|
|
|
Anne-Rose Schut, NL
|
|
|
ESSO40-0407 – ‘Cost-effectiveness of the three EMA-approved adjuvant systemic therapies in patients with high-risk melanoma: a model-based economic evaluation’
|
|
|
Evalyn Mulder, NL
|
|
|
ESSO40-0598 – A comparison of the efficacy of Isolated limb perfusion for the treatment of in-transit melanoma in patients previously treated with immunotherapy and in immunotherapy naive patients.
|
|
|
Emma Davies, GB
|
|
|
ESSO40-0323 – MET Targeted Molecular Fluorescence Guided Imaging and Quantitative Spectroscopy for the Detection of Lymph Node Metastases in Papillary Thyroid Cancer
|
|
|
Pascal Jonker, NL
|
|
|
|
|
|
Breast Scientific Symposium: Management of local recurrences
|
|
|
12:00–13:30 (AUDITORIUM VII)
|
|
|
Chair: Joaquim Abreu, PT
Co-Chair: Riccardo Audiosio, SE
|
|
12:00
|
Re lumpectomy
|
|
|
Speaker: MK Tasoulis, UK
|
|
12:15
|
Recurrent SLN
|
|
|
Speaker: Sabrina Maaskant-Braat, NL
|
|
12:30
|
Re irradiation
|
|
|
Speaker: Philip Poortmans, BE
|
|
12:45
|
Patient perspectives on locoregional recurrence of breast cancer
|
|
|
Kathi Apostolidis, GR
|
|
13:00
|
ESSO40-0255 – Annelieke Lemij, NL
Predicting postoperative complications and their impact on quality of life and functional status in older patients with breast cancer
|
|
13:10
|
ESSO40-0321 – Louise Merker, GB
Breast Cancer Management in the over 80’s population: are we being fair?
|
|
13:20
|
ESSO40-0497 – Eirini Pantiora, SE
Electronic Patient Reported Outcome Measures (ePROMs) in Patients With Breast Disease: An Open-label, Randomized Controlled Trial on Patient Reported Experience Measures (PREMs) and Effectivity
|
|
|
|
|
|
UGI Scientific Symposium: State of the Art in Oesophageal and Gastric Cancer
|
|
|
12:00–13:30 (AUDITORIUM VI)
|
|
|
Chair: William Allum, UK
Co-chair: Domenico D’Ugo, IT
|
|
12:00
|
Textbook outcome (TO) of gastric cancer surgery
|
|
|
Speaker: Han-Kwang Yang, KR (virtual presentation)
|
|
12:20
|
Is tumour biology in gastric cancer different between Eastern and Western countries?
|
|
|
Speaker: Fatima Carneiro, PT
|
|
12:40
|
ESSO40-0225 – Sander Ubels, NL
TreatmENT of AnastomotiC LEakage after esophagectomy (TENTACLE - Esophagus) study: efficacy of different initial treatment strategies for anastomotic leakage
|
|
12:50
|
ESSO40-0236 - Stefanie Brunner, DE
The CARDIA Trial
|
|
13:00
|
ESSO40-0264 – Mirte Ketel, NL
Competency assessment tool for Minimally Invasive Esophagectomy: development and preliminary construct validity and reliability results
|
|
13:10
|
ESSO40-0474 – Ben Eyck, NL
Outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal squamous cell carcinoma in East Asia versus Western Europe
|
|
13:20
|
Proffered paper presentation
|
|
|
|
|
|
Colorectal Cancer Scientific Symposium: Locally advanced colorectal cancer
|
|
|
14:45–16:15 (AUDITORIUM VII)
|
|
|
Chair: Geerard Beets, NL
Co-chair: Ana Raimundo, PT
|
|
14:45
|
Neoadjuvant treatment in colonic cancer
|
|
|
Speaker: Andres Cervantes, SP
|
|
15:05
|
Neoadjuvant treatment in rectal cancer
|
|
|
Speaker: Michel Rivoire, FR
|
|
15:25
|
Imaging in advanced colorectal cancer
|
|
|
Speaker: daniele regge, it
|
|
15:45
|
Patterns of locoregional failure in patients treated within the RAPIDO trial/The influence of total neoadjuvant treatment on the development and location of distant metastases in patients with locally advanced rectal in the RAPIDO trial
|
|
|
Speaker: Esmee Dijkstra + Renu Bahadoer
|
|
15:55
|
Proffered Paper
|
|
|
|
|
16:05
|
Feasibility and safety of laparoscopic approach in D3 lymph node dissection for colon cancer surgery. COLD trial: analysis of 116 patients included in main center
|
|
|
Speaker: Aleksandra Olkina, RU
|
|
|
|
|
|
Colorectal Cancer Scientific Symposium: Locally advanced colorectal cancer
|
|
|
14:45–16:15 (AUDITORIUM VII)
|
|
|
Chair: Geerard Beets, NL
Co-chair: Ana Raimundo, PT
|
|
14:45
|
Neoadjuvant treatment in colonic cancer
|
|
|
Speaker: Andres Cervantes, SP
|
|
15:05
|
Neoadjuvant treatment in rectal cancer
|
|
|
Speaker: Michel Rivoire, FR
|
|
15:25
|
Imaging in advanced colorectal cancer
|
|
|
Speaker: daniele regge, it
|
|
15:45
|
Patterns of locoregional failure in patients treated within the RAPIDO trial/The influence of total neoadjuvant treatment on the development and location of distant metastases in patients with locally advanced rectal in the RAPIDO trial
|
|
|
Speaker: Esmee Dijkstra + Renu Bahadoer
|
|
15:55
|
Proffered Paper
|
|
|
|
|
16:05
|
Feasibility and safety of laparoscopic approach in D3 lymph node dissection for colon cancer surgery. COLD trial: analysis of 116 patients included in main center
|
|
|
Speaker: Aleksandra Olkina, RU
|
|
|
|
|
|
Scientific Symposium: Clinical research in surgical oncology: integrating multiple disciplines (session supported by the AntiCancer Fund)
|
|
|
14:45–16:15 (AUDITORIUM VI)
|
|
|
Chair: Serge Evrard, FR
Co-chair: Wim Ceelen, BE
|
|
14:45
|
Clinical research in surgical oncology matters – The funder’s perspective
|
|
|
Speaker: Gauthier Bouche, BE
|
|
14:55
|
Surgeon-led (neo)-adjuvant trial
|
|
|
Speaker: Dr. Winan Van Houdt, Netherlands Cancer Institute, NL
|
|
15:15
|
Methodological aspects of surgical trials
|
|
|
Speaker: tba
|
|
15:35
|
Surgical procedures
|
|
|
Speaker: André Mihaljevic, DE
|
|
15:55
|
Surgical oncology clinical trials infrastructure
|
|
|
Speaker: Wim Ceelen (BE)
|
|
|
|
|
|
Posters in the spotlight - Upper GI Cancer & HPB
|
|
|
Tuesday, 16:15 – 16:45 (10’ break; presentations start at 16:25)
|
|
|
Moderators: TBD
|
|
|
ESSO40-0178 – Long-term outcome after portal vein resection during pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matched analysis
|
|
|
James Russell, GB
|
|
|
ESSO40-0564 – Feasibility of multimdodal prehabilitation to enhance preoperative functional capacity of esophageal cancer patients during concurrent neoadjuvant chemotherapies - a pilot interventional study
|
|
|
Jade St-Pierre, CA
|
|
|
ESSO40-0588 – Patients’ preferences for active surveillance or standard oesophagectomy: a discrete choice experiment
|
|
|
Berend Van Der Wilk, NL
|
|
|
ESSO40-0096 – Transthoracic esophagectomy compared to transhiatal extended gastrectomy for adenocarcinoma of the esophagogastric junction: an international retrospective cohort study
|
|
|
Carlo Alberto De Pasqual, IT
|
|
|
ESSO40-0281 – Global Impact of COVID-19 pandemic on Gastric Cancer Treatment: findings from a global cross-sectional multicentre study (GLEOHUG-GC)
|
|
|
Johnn Henry Herrera Kok, ES
|
|
|
|
|
|
Interdisciplinary Scientific Symposium: Artificial intelligence
|
|
|
16:45–18:15 (AUDITORIUM VII)
|
|
|
Chair: Dara Lundon, IR
Co-chair: Andreas Brandl, PT
|
|
16:45
|
Translating AI innovations into clinical practice
|
|
|
Speaker: Pearse Keane, UK (virtual presentation)
|
|
17:05
|
Demystifying Radiomics: A blueprint for creating value across the cancer continuum
|
|
|
Speaker: Nickolas Papanikolaou, PT
|
|
17:20
|
Artificial Intelligence and Virtual Reality applications in telehealth
|
|
|
Dara Lundon, IRL
|
|
17:40
|
Artificial Intelligence and Augmented Reality in Breast Cancer Surgery
|
|
|
Speaker: Pedro Gouveia, PT
|
|
17:55
|
Deep learning and generative Adversarial Networks applications in oncologic imaging
|
|
|
Speaker: Maria Elena Laino, IT
|
|
|
|
|
|
HPB Debate: All pancreatic cancer patients should receive neoadjuvant therapy before resection
|
|
|
16:45–18:15 (AUDITORIUM VI)
|
|
|
Moderator: Kjetil Soreide, NO
|
|
16:45
|
Speaker in favour: Marc Besselink, NL
|
|
17:05
|
Speaker against: Thilo Hackert, DE
|
|
17:25
|
Discussion & Voting
|
|
17:45
|
ESSO40-0620 - Ronald M Van Dam, NL
Laparoscopic versus open hemihepatectomy: The ORANGE II PLUS multicenter randomized controlled trial
|
|
17:55
|
ESSO40-0540 – Ulrike Heger, DE
Surgical resection of isolated local recurrence in pancreatic carcinoma
|
|
18:05
|
ESSO40-0424 – Jana Hopstaken, NL
Impact of multicenter diagnostic workup on time-to-diagnosis and time-to-treatment in patients with pancreatic ductal adenocarcinoma: a nationwide analysis
|
|
|
|
|
|
|
|
|
|
|
|
Wednesday 10th November
|
|
|
|
|
|
Scientific Symposium: Pelvic malignancy
|
|
|
08:30–09:30 (AUDITORIUM VII)
|
|
|
Chair: S. Gonzalez-Moreno, SP
Co-Chair: Joaquim Abreu, PT
|
|
08:30
|
PelvEx collaborative group: outcome of surgery for advanced pelvic malignancies
|
|
|
Speaker: Des Winter, IRL
|
|
08:47
|
Management of locally advanced rectal Cancer: Role of IORT
|
|
|
Speaker: Lucio Santos, PT
|
|
09:04
|
Reconstruction challenges after extended pelvic surgery
|
|
|
Speaker: rui barbosa, pt
|
|
09:21
|
Training in advanced pelvic malignancy across Europe and beyond – an EYSAC snapshot analysis
|
|
|
SPEAKER: Andreas Brandl, PT
|
|
|
|
|
|
HPB Scientific Symposium: Surgery of tomorrow
|
|
|
Advances in robotics, imaging and AI towards surgical cancer management. Tumour biology and immunology and its influence on surgical outcomes
|
|
|
08:30–09:30 (AUDITORIUM VI)
|
|
|
Chair: Graeme J. Poston, UK
Co-Chair: tba
|
|
08:30
|
Impact on AI on surgery
|
|
|
Speaker: Marc Besselink, nl
|
|
08:50
|
Genomic signatures of Hepatocellular carcinoma in liver transplant
|
|
|
Speaker: Jose B Pereira-Leal, Lisbon, PT
|
|
09:10
|
Immunoscore in metastatic colorectal cancer
|
|
|
Speaker: kjetil soreide, no
|
|
|
|
|
|
Colorectal Scientific Symposium: Early colorectal cancer
|
|
|
09:30–11:00 (AUDITORIUM VII)
|
|
|
Chair: Des Winter, IRL
Co-Chair: Andreas Brandl, PT
|
|
09:30
|
Endoscopic approaches
|
|
|
Speaker: mario dinis ribeiro, pt
|
|
09:50
|
Transanal local excision
|
|
|
Speaker: antonino spinelli, it
|
|
10:10
|
Organ preservation in rectal cancer
|
|
|
Speaker: Geerard Beets, NL
|
|
10:30
|
ESSO40-0100 – Anders Lyng Ebbehøj, DK
Risk factors for lymph node metastases in T1 colorectal cancer differ according to tumour morphology
|
|
10:40
|
ESSO40-0188 – Petra Custers, NL
Quality of life and functional outcome of rectal cancer patients following a Watch-and-Wait approach
|
|
10:50
|
ESSO40-0106 – Renu Bahadoer, NL
Should watch and wait be offered to rectal cancer patients younger than 50 years after a clinical complete response?
|
|
|
|
|
|
Joint session of the Surgical Oncology Section of the Portuguese Society of Oncology (SOC-SPO) and Brazilian Society of Surgical Oncology (SBCO): Education and Training in Surgical Oncology
|
|
|
09:30–11:00 (AUDITORIUM VI)
Chair: Joaquim Abreu, PT
Co-chair: Alexandre Ferreira, BR
|
|
09:30
|
Surgeons who treat cancer need to specialize?
Os cirurgiões que tratam cancro devem especializar-se?
|
|
|
Speaker: Rodrigo Nascimento Pinheiro
|
|
09:45
|
Surgical Oncology Residency Program in Brazil
Residência de Oncologia Cirúrgica no Brasil
|
|
|
Speaker: Alexandre Ferreira, BR
|
|
10:00
|
Postgraduate Education in Surgical Oncology in Portugal
Ensino Pós-graduado de Oncologia Cirúrgica em Portugal
|
|
|
Speaker: Lucio Santos, PT
|
|
10:30
|
ESSO40-0207 – Beatriz Costeira, PT
Long-term locoregional recurrence after breast cancer surgery
|
|
10:40
|
ESSO40-0478 – Ana Margarida Correia, PT
Hereditary Diffuse Gastric Cancer – Experience of a Portuguese Oncology Center
|
|
10:50
|
ESSO40-0430 - Sara Rodrigues, PT
Surgical Treatment of Esophageal Cancer – The First 100 Cases of a Reference Center in Minimally Invasive Approach
|
|
|
|
|
|
Posters in the spotlight (Colorectal Cancer)
|
|
|
Wednesday, 11:00 – 11:30 (10’ break; presentations start at 11:10)
|
|
|
Chair: TBD
|
|
11:30
|
ESSO40-0476 – KHANS technique can reduce postoperative morbidity in rectal cancer surgery and reduce overall costs for hospitalisation
|
|
|
Speaker: Mohid Malik, GB
|
|
11:50
|
ESSO40-0218 – Different surgical approaches in the treatment of rectal NETs considering the biological and morphological features of the neuroendocrine tumors
|
|
|
Speaker: Mykola Zubaryev, UA
|
|
12:10
|
ESSO40-0140 – Impact of COVID-19 on Colorectal Cancer Patients at Basildon and Southend University Hospitals
|
|
|
Speaker: Abdalla Saad Abdalla Al-Zawi, GB
|
|
|
|
|
|
Interdisciplinary Session: Advances in Surgical Oncology
|
|
|
11:30–13:00 (AUDITORIUM VII)
|
|
|
Chair: G. Beets, NL
Co-chair: Nuno Abecasis, PT
|
|
11:30
|
Advances in oncological imaging
|
|
|
Speaker: daniele regge, it
|
|
11:50
|
The surgical oncologist of the future
|
|
|
Speaker: Isabel Rubio, SP
|
|
12:10
|
Towards minimally invasive cancer surgery
|
|
|
Speaker: Douglas Tyler, USA
|
|
12:30
|
Use of PROMs as an outcome measure
|
|
|
Patient advocate point of view: Robert Greene, UK (ECPC Board member)
|
|
12:50
|
Discussion
|
|
|
|
|
|
Colorectal Cancer Debate: Should a D3 lymphadenectomy be standard in colon cancer?
|
|
|
11:30–13:00 (AUDITORIUM VI)
|
|
|
Chair: Michel Rivoire, FR
Co-chair: Gabriela Moeslein, DE
|
|
11:30
|
Speaker in favour: Felix Aigner, DE
|
|
11:45
|
Speaker against: Des Winter, IRL
|
|
12:00
|
Discussion & Voting
|
|
12:10
|
ESSO40-0615 – Barbara Noiret, FR
Postoperative mortality after cytoreductive surgery alone for peritoneal metastasis of colorectal origin need centralization in expert centers: a national study of 5,893 patients
|
|
12:20
|
ESSO40-0371 – Michelle Dietz, NL
Survival Outcomes after Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in patients with Synchronous versus Metachronous onset of Peritoneal Metastases of Colorectal Carcinoma
|
|
12:30
|
ESSO40-0399 – Enes Kacmaz, NL
Minimally invasive versus open resection of neuroendocrine tumours of the colon: a nationwide population-based study
|
|
12:40
|
ESSO40-0621 – Michael Kelly, IE
Surgical outcomes in older patients with peritoneal malignancy treated with cytoreductive surgery and hipec: experience the uk and ireland colorectal peritoneal metastases study group
|
|
12:50
|
ESSO40-0351 – Dirk Van Genechten, BE
Survey of Challenges in Access to Diagnostics and Treatment for Neuroendocrine Tumor (NET) Patients (SCAN) – application of surgery in treatment of SI NETs
|
|
|
|
|
|
Plenary Session: Congress Highlights and Closing Remarks
|
|
|
13:00–13:30 (AUDITORIUM VI8)
|
|
|
Chair: Domenico D’Ugo, IT
Co-chair: Joaquim Abreu, PT
|
|
13:00
|
Key figures of ESSO 40 (abstracts, registrations)
|
|
13:03
|
Best Proffered Paper Award, Best Poster Award, EBSQ Surgical Oncology exam medal
|
|
13:06
|
Congress Highlights
|
|
13:06
|
Speaker 1: Highlights in HPB/Colorectal cancer surgery
|
|
13:11
|
Speaker 2: Highlights in breast cancer surgery
|
|
13:16
|
Speaker 3: Highlights in gastric cancer
|
|
13:21
|
Closing Remarks
|
